ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

IRON Disc Medicine Inc

47,1478
7,99 (20,40%)
14 Jun 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Disc Medicine Inc IRON NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
7,99 20,40% 47,1478 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
39,16 39,11 48,45 46,27 39,16
mais cotações »

Notícias Recentes

Data Hora Fonte Título
14/06/202409:03GLOBEDisc Medicine Announces Underwritten Offering of Common..
14/06/202408:30GLOBEDisc Medicine Presents Positive Clinical Data Across..
30/05/202410:00GLOBEDisc Medicine to Participate in the Jefferies Global..
14/05/202411:30GLOBEDisc Medicine Announces Multiple Presentations Across..
13/05/202409:00GLOBEDisc Medicine to Participate in the H.C. Wainwright..
09/05/202409:00GLOBEDisc Medicine Reports First Quarter 2024 Financial Results..
01/04/202409:00GLOBEDisc Reports Topline Results from Phase 2 AURORA Study of..
21/03/202409:00GLOBEDisc Medicine Reports Fourth Quarter and Full Year 2023..
06/03/202418:30GLOBEDisc Medicine to Participate in the Leerink Partners Global..
26/02/202410:30GLOBEDisc Medicine Expands Leadership Team with Appointment of..
20/02/202410:30GLOBEDisc Medicine Receives FDA Fast Track Designation for..
09/02/202411:00GLOBEDisc Medicine Receives FDA Orphan Drug Designation for..
07/02/202410:00GLOBEDisc Medicine Strengthens Leadership Team with Appointment..
03/01/202419:00GLOBEDisc Medicine to Present at the 42nd Annual J.P. Morgan..
20/12/202318:30GLOBEDisc Medicine Announces Retirement of Brian MacDonald, MB,..
11/12/202322:30GLOBEDisc Presents Positive Updated Results from Phase 2 BEACON..
11/12/202314:00GLOBEDisc Presents Initial Positive Data from Ongoing Phase 1b/2..
14/11/202318:44GLOBEDisc Medicine Announces Grant of US Patent for Methods of..
09/11/202310:30GLOBEDisc Medicine Reports Third Quarter 2023 Financial Results..
08/11/202318:30GLOBEDisc Medicine to Participate in Upcoming Investor..
02/11/202310:00GLOBEDisc Medicine Announces Multiple Presentations Across..
23/10/202310:15GLOBEDisc Medicine Announces Planned Departure of Chief Financial..
03/10/202309:30GLOBEDisc Medicine Initiates a Phase 1 Study of DISC-3405..
20/09/202318:18DJNDisc Medicine Polycythemia Vera Treatment MWTX-003 Gets FDA..
20/09/202317:30GLOBEDisc Medicine Receives FDA Fast Track Designation for..
30/08/202317:15GLOBEDisc Medicine to Participate in Upcoming Investor..
11/08/202309:00GLOBEDisc Medicine Reports Second Quarter 2023 Financial Results..
27/07/202310:00GLOBEDisc Medicine Announces First Patient Enrolled in Phase 1/2..
22/06/202317:15GLOBEDisc Medicine Announces Closing of Public Offering of Common..

Seu Histórico Recente